Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Screening interval based on initial PSA: Data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Zaina Qureshi South Carolina College of Pharmacy, University of South Carolina PLCO May 19, 2011 2011-0087
Predicting how the ROCA algorithm would have performed in PLCO Paul Pinsky NCI, DCP, EDRG PLCO May 19, 2011 2011-0089
Prediction of true positive lung cancer in abnormal suspicious CT lung screens Martin Tammemagi Henry Ford Health System NLST May 17, 2011 201105-0015
Genome-wide Association Study of Benign Prostatic Hyperplasia Sonja Berndt NCI, DCEG, OEEB PLCO Apr 20, 2011 2011-0078
Coffee, tea, caffeine and the risk of cancer Mia Hashibe University of Utah PLCO Apr 4, 2011 2011-0052
Prostate cancer risk in relation to obesity and diabetes: A pooled analysis (Cohort Consortium Study) Ann Hsing NCI, DCEG, HREB PLCO Mar 25, 2011 2011-0053
KIR/HLA/MIR148A variation and risk of prostate cancer Stella Koutros NCI, DCEG, OEEB PLCO Mar 9, 2011 2011-0039
Mitochondrial DNA Copy Number and Prostate Cancer Risk Sonja Berndt NCI, DCEG, OEEB PLCO Mar 9, 2011 2011-0037
Risk of multiple myeloma in relation to plasma adipokine levels: a nested case-control study in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Jonathan Hofmann DCEG - Other PLCO Mar 9, 2011 2011-0028
Prostate Cancer Survival in PLCO: The effect of screening Paul Pinsky NCI, DCP, EDRG PLCO Mar 3, 2011 2010-0301
Risk factors for endometrial cancer in black and white women in the Epidemiology of Endometrial Cancer Consortium (E2C2) Sara Olson Memorial Sloan-Kettering Cancer Center PLCO Feb 2, 2011 2010-0290
Oxford Pooling Project: Prostate (endogenous hormones and nutritional biomarkers) Amanda Black NCI, DCEG, EBP PLCO Jan 31, 2011 2010-0320
Inflammatory Markers and Subsequent Risk of Prostate Cancer Ann Hsing NCI, DCEG, HREB PLCO Jan 20, 2011 2010-0034
CT Individual Dose Project Randell Kruger Marshfield Clinic Research Foundation NLST Dec 28, 2010 201012-0028
Side-effects and complications of prostate biopsies, radical prostatectomies and prostate cancer diagnoses within the PLCO Trial Amanda Black NCI, DCEG, EBP PLCO Nov 23, 2010 2010-0265
Arylamine hemoglobin (Hgb)-adducts and bladder cancer risk in never-smokers within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) Jonine Figueroa NCI PLCO Nov 22, 2010 2010-0113
Variability Among NLST Radiologists Paul Pinsky National Cancer Institute NLST Nov 19, 2010 201011-0010
Inflammation markers and risk of endometrial and ovarian cancer Nicolas Wentzensen MD NCI PLCO Nov 18, 2010 2010-0211
Inflammatory Markers and Smoking-Associated Cancers Meredith Shiels NCI PLCO Nov 18, 2010 2010-0201
Prospective Oral HPV Detection and Risk of Head and Neck Cancers Ilir Agalliu Other (Specify) PLCO Nov 18, 2010 2010-0153